Janine Thomas
Investor Relations
Replay available
Outlook Therapeutics, Inc. (OTLK) Q2 2024 Earnings Call
Outlook Therapeutics, Inc. (NASDAQ: OTLK) Q2 2024 earnings conference call, held 2024-05-16. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Russell Trenary
President and Chief Executive Officer
Lawrence Kenyon
Chief Financial Officer
Julian Harrison
Analyst, BTIG
Eddie Hickman
Analyst, Guggenheim Securities
Douglas Schauer
Analyst, H.C. Wainwright
Tim Chang
Analyst, Capital One
Kemp Dolliver
Analyst, Brookline Capital Markets
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Outlook Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.189 -- 00:00:05.812 Hello and welcome to the Outlook Therapeutics inaugural quarterly update conference call 00:00:05.812 -- 00:00:07.353 and webcast. 00:00:07.353 -- 00:00:11.876 As a brief reminder, all participants are currently in a listen-only mode. 00:00:11.876 -- 00:00:16.479 If anyone requires operator assistance during the event, please press star zero on your 00:00:16.479 -- 00:00:21.942 telephone keypad. Following the presentation, there will be a question and answer session. 00:00:21.942 -- 00:00:26.385 Note that this webcast is being recorded at the company's request and a replay will be 00:00:26.385 -- 00:00:30.532 made available on the company's website following the end of the event. 00:00:30.532 -- 00:00:36.215 It is now my pleasure to turn the call over to Janine Thomas of Investor Relations. 00:00:36.316 -- 00:00:40.479 Thank you, Daryl. At this time, I would like to remind our listeners that remarks made 00:00:40.479 -- 00:00:45.463 during this webcast may state management's intentions, beliefs, expectations, or future 00:00:45.463 -- 00:00:50.106 projections. These are forward-looking statements and involve risks and uncertainties. 00:00:50.106 -- 00:00:54.029 Forward-looking statements on this call are made pursuant to the safe harbor provisions 00:00:54.029 -- 00:00:59.318 of the federal securities laws and are based on Outlook Therapeutics' current expectations 00:00:59.318 -- 00:01:01.900 and actual results could differ materially. 00:01:01.900 -- 00:01:06.003 As a result, you should not place undue reliance on any forward-looking statements. 00:01:06.003 -- 00:01:10.827 Some of the factors that could cause actual results to differ materially from these contemplated 00:01:10.827 -- 00:01:15.051 by such forward-looking statemen...